Sanjay Gajendra Sells 94,971 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) COO Sanjay Gajendra sold 94,971 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the sale, the chief operating officer owned 1,531,301 shares of the company’s stock, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Astera Labs Trading Down 2.2%

NASDAQ ALAB opened at $129.68 on Friday. The stock has a market capitalization of $21.90 billion, a price-to-earnings ratio of 106.30, a PEG ratio of 2.61 and a beta of 1.50. The business’s 50 day moving average is $160.40 and its two-hundred day moving average is $174.06. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The business had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same period last year, the firm earned $0.37 EPS. The company’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Raymond James Financial assumed coverage on shares of Astera Labs in a report on Friday, November 21st. They issued a “hold” rating for the company. Roth Mkm increased their target price on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Wall Street Zen lowered Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Barclays set a $165.00 price target on Astera Labs in a report on Thursday, January 15th. Finally, Stifel Nicolaus lifted their price objective on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $192.89.

Get Our Latest Stock Report on ALAB

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Zacks highlights rising AI connectivity demand and Astera’s expansion of NVLink and Scorpio product lines, framing a multiyear market opportunity that could support revenue growth. ALAB Rides on Strong Connectivity Demand
  • Positive Sentiment: Seeking Alpha notes strong fundamentals: revenue more than doubled YoY, very healthy free cash flow margins (>30%), roughly $1.19B cash and no debt — giving Astera flexibility to invest or absorb near‑term headwinds. The Great Astera Labs Reset
  • Positive Sentiment: Recent quarterly results beat expectations (EPS and revenue) and management set Q1 2026 guidance; continued demand for high‑speed interconnects supports the growth narrative. Earnings & Guidance
  • Neutral Sentiment: Reported short-interest data is effectively immaterial/odd (reported as zero), so short‑pressure does not explain intraday moves — it’s a non‑factor for current trading dynamics. Short Interest Report
  • Negative Sentiment: CEO sale: Jitendra Mohan sold 94,971 shares at ~$123.81 (~$11.8M), trimming his stake by ~6.14% — a sizeable single‑day sale that can be viewed negatively by investors. CEO Form 4
  • Negative Sentiment: COO sale: Sanjay Gajendra sold 94,971 shares at ~$123.81 (~$11.8M), reducing his holding by ~5.84% — another large insider disposition on the same date that amplifies concern. COO Form 4
  • Negative Sentiment: CFO sale: Michael Truett Tate sold 12,001 shares at ~$123.81 (~$1.49M), lowering his stake by ~5.88% — adds to the cluster of senior‑level selling. CFO Form 4
  • Negative Sentiment: General Counsel sale: Philip Mazzara sold 4,849 shares at ~$123.80 (~$600k), a smaller but concurrent insider reduction — multiple senior officers selling the same day increases perceived signal of liquidity taking or diversification. GC Form 4

Institutional Investors Weigh In On Astera Labs

Institutional investors and hedge funds have recently bought and sold shares of the stock. Lido Advisors LLC increased its position in Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after buying an additional 57 shares in the last quarter. Perigon Wealth Management LLC boosted its stake in shares of Astera Labs by 6.2% during the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after acquiring an additional 73 shares during the last quarter. Clearstead Advisors LLC increased its position in Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after purchasing an additional 76 shares in the last quarter. Sound Income Strategies LLC raised its stake in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after purchasing an additional 76 shares during the last quarter. Finally, Venturi Wealth Management LLC raised its stake in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.